Every compound is manufactured to research-grade standards and intended strictly for laboratory and research use. Consistent quality you can build a reproducible protocol around.
Batch number on every vial
Published Certificates of Analysis
Purity verified by third-party testing
Temperature-sensitive compounds are stored and shipped under controlled conditions, so material arrives in the state your research requires. Expert support on hand at every step.
TRH peptide, also known as Thyrotropin-releasing hormone peptide, is a synthetically produced tripeptide designed to replicate a naturally occurring neuroendocrine signal found in the hypothalamus. It consists of the Pyr-His-Pro-NH₂ sequence and has a molecular weight of approximately 362.38 g/mol.
In laboratory production, this peptide is created using solid-phase peptide synthesis (SPPS), a method that allows precise assembly of short amino acid chains. After synthesis, purification is performed using high-performance liquid chromatography, followed by analytical verification, such as mass spectrometry, to confirm sequence accuracy. The final material is typically lyophilized into a high-purity powder for controlled experimental use.
In TRH neuropeptide research, it serves as a reliable model for studying brain–endocrine communication.
For laboratory research use only.
This peptide is widely studied for its role in neuroendocrine regulation, particularly within the hypothalamic–pituitary–thyroid axis. TRH has been examined for its contribution to signaling processes that regulate hormone release from pituitary cells. These studies help researchers understand feedback mechanisms that maintain endocrine balance.
Beyond hormone-related research, TRH neuropeptide research also explores its involvement in central nervous system activity. Investigations include its potential influence on synaptic plasticity, motor coordination, and autonomic signaling, as well as its role in neurotransmitter release and neural network communication in controlled models.
Data from TRH research peptide studies include findings from both in-vitro and preclinical models. In cell-based assays, concentrations typically range from 1–100 nanomolar, which has been sufficient to stimulate measurable signaling responses in pituitary cell systems. These controlled conditions allow researchers to evaluate how the peptide influences endocrine activity.
Studies involving TRH peptide have also examined its effects in animal models, where it is used to observe hormone release patterns and neural signaling behavior. Reported findings focus on intracellular signaling activity, neuronal excitability, and coordinated cellular responses, all within structured laboratory environments.
Store the lyophilized product at –20°C in a controlled laboratory setting. Protect from light, moisture, and temperature fluctuations during handling.
After reconstitution, store the solution at 2–8°C and handle according to standard laboratory practices. Preparing aliquots is recommended to avoid repeated freeze–thaw cycles during handling.
Compliance Notice: This product is intended for laboratory research use only and is not approved for human or veterinary use. It is not intended for diagnostic, therapeutic, or clinical applications. Any reference to biological activity or potential effects is based solely on preclinical or in-vitro findings and should not be interpreted as validated clinical outcomes. Researchers are responsible for ensuring proper handling, storage, and disposal in accordance with institutional, federal, and international guidelines.
Subscribe for exclusive offers and updates on new arrivals